Back to Journals » ClinicoEconomics and Outcomes Research » Volume 8

ClinicoEconomics and Outcomes Research


Archive: Volume 8, 2016

Patient-reported financial barriers to adherence to treatment in neurology

Moura LMVR, Schwamm EL, Moura Junior V, Seitz MP, Hoch DB, Hsu J, Schwamm LH

ClinicoEconomics and Outcomes Research 2016, 8:685-694

Published Date: 17 November 2016

Evaluating increased resource use in fibromyalgia using electronic health records

Margolis JM, Masters ET, Cappelleri JC, Smith DM, Faulkner S

ClinicoEconomics and Outcomes Research 2016, 8:675-683

Published Date: 16 November 2016

Economic impact of longer battery life of cardiac resynchronization therapy defibrillators in Sweden

Gadler F, Ding Y, Verin N, Bergius M, Miller JD, Lenhart GM, Russell MW

ClinicoEconomics and Outcomes Research 2016, 8:657-666

Published Date: 31 October 2016

Residual cardiovascular risk in patients who received lipid-lowering treatment in a real-life setting: retrospective study

Perrone V, Sangiorgi D, Buda S, Degli Esposti L

ClinicoEconomics and Outcomes Research 2016, 8:649-655

Published Date: 25 October 2016

Health care resource use and costs associated with possible side effects of high oral corticosteroid use in asthma: a claims-based analysis

Luskin AT, Antonova EN, Broder MS, Chang EY, Omachi TA, Ledford DK

ClinicoEconomics and Outcomes Research 2016, 8:641-648

Published Date: 25 October 2016

Relative cost-effectiveness of using an extensively hydrolyzed casein formula in managing infants with cow’s milk allergy in Brazil

Guest JF, Yang AC, Oba J, Rodrigues M, Caetano R, Polster L

ClinicoEconomics and Outcomes Research 2016, 8:629-639

Published Date: 19 October 2016

The direct health-care burden of valvular heart disease: evidence from US national survey data

Moore M, Chen J, Mallow PJ, Rizzo JA

ClinicoEconomics and Outcomes Research 2016, 8:613-627

Published Date: 18 October 2016

Bringing patient centricity to diabetes medication access in Canada

Glennie JL, Kovacs Burns K, Oh P

ClinicoEconomics and Outcomes Research 2016, 8:599-611

Published Date: 17 October 2016

Disease progression and health care resource consumption in patients affected by hepatitis C virus in real practice setting

Perrone V, Sangiorgi D, Buda S, Degli Esposti L

ClinicoEconomics and Outcomes Research 2016, 8:591-597

Published Date: 14 October 2016

Cost-effectiveness of eplerenone in NYHA class II chronic heart failure patients with reduced LVEF: an analysis for Greece

Athanasakis K, Bilitou A, Lee D, Karampli E, Karavidas A, Parissis J, Sykara G, Kyriopoulos J

ClinicoEconomics and Outcomes Research 2016, 8:583-590

Published Date: 12 October 2016

Evaluating health-related quality of life in type 1 diabetes: a systematic literature review of utilities for adults with type 1 diabetes

Smith-Palmer J, Bae JP, Boye KS, Norrbacka K, Hunt B, Valentine WJ

ClinicoEconomics and Outcomes Research 2016, 8:559-571

Published Date: 7 October 2016

Cost-effectiveness analysis of fesoterodine flexible dose in newly diagnosed patients with overactive bladder in routine clinical practice in Spain

Peral C, Sánchez-Ballester F, García-Mediero JM, Ramos J, Rejas J

ClinicoEconomics and Outcomes Research 2016, 8:541-550

Published Date: 26 September 2016

Cost-effectiveness analysis of online hemodiafiltration versus high-flux hemodialysis

Ramponi F, Ronco C, Mason G, Rettore E, Marcelli D, Martino F, Neri M, Martin-Malo A, Canaud B, Locatelli F

ClinicoEconomics and Outcomes Research 2016, 8:531-540

Published Date: 22 September 2016

Cost-effectiveness of dipeptidyl peptidase-4 inhibitor monotherapy in elderly type 2 diabetes patients in Thailand

Permsuwan U, Dilokthornsakul P, Saokaew S, Thavorn K, Chaiyakunapruk N

ClinicoEconomics and Outcomes Research 2016, 8:521-529

Published Date: 21 September 2016

A hospital cost analysis of a fibrin sealant patch in soft tissue and hepatic surgical bleeding

Corral M, Ferko N, Hogan A, Hollmann SS, Gangoli G, Jamous N, Batiller J, Kocharian R

ClinicoEconomics and Outcomes Research 2016, 8:507-519

Published Date: 21 September 2016

Patient-level costs of major cardiovascular conditions: a review of the international literature

Nicholson G, Gandra SR, Halbert RJ, Richhariya A, Nordyke RJ

ClinicoEconomics and Outcomes Research 2016, 8:495-506

Published Date: 21 September 2016

Economic evaluation of eribulin as second-line treatment for metastatic breast cancer in South Korea

Tremblay G, Majethia U, Breeze JL, Kontoudis I, Park J

ClinicoEconomics and Outcomes Research 2016, 8:485-493

Published Date: 19 September 2016

Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain

Casado LF, Burgos A, González-Haba E, Loscertales J, Krivasi T, Orofino J, Rubio-Terres C, Rubio-Rodríguez D

ClinicoEconomics and Outcomes Research 2016, 8:475-484

Published Date: 21 September 2016

Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district

Polilli E, Cento V, Restelli U, Ceccherini-Silberstein F, Aragri M, Di Maio VC, Sciacca A, Santoleri F, Fazii P, Costantini A, Perno CF, Parruti G

ClinicoEconomics and Outcomes Research 2016, 8:467-473

Published Date: 14 September 2016

Targeting improved patient outcomes using innovative product listing agreements: a survey of Canadian and international key opinion leaders

Thompson M, Henshall C, Garrison LP, Griffin AD, Coyle D, Long S, Khayat ZA, Anger DL, Yu R

ClinicoEconomics and Outcomes Research 2016, 8:427-433

Published Date: 26 August 2016

A systematic review of observational studies evaluating costs of adverse drug reactions

Batel Marques F, Penedones A, Mendes D, Alves C

ClinicoEconomics and Outcomes Research 2016, 8:413-426

Published Date: 24 August 2016

The epidemiology and burden of Alzheimer’s disease in Taiwan utilizing data from the National Health Insurance Research Database

Hung YN, Kadziola Z, Brnabic AJM, Yeh JF, Fuh JL, Hwang JP, Montgomery W

ClinicoEconomics and Outcomes Research 2016, 8:387-395

Published Date: 2 August 2016

Work intensity in sacroiliac joint fusion and lumbar microdiscectomy

Frank C, Kondrashov D, Meyer SC, Dix G, Lorio M, Kovalsky D, Cher D

ClinicoEconomics and Outcomes Research 2016, 8:367-376

Published Date: 26 July 2016

Characterizing individual painDETECT symptoms by average pain severity

Sadosky A, Koduru V, Bienen EJ, Cappelleri JC

ClinicoEconomics and Outcomes Research 2016, 8:361-366

Published Date: 26 July 2016

The use of sugammadex for bariatric surgery: analysis of recovery time from neuromuscular blockade and possible economic impact

De Robertis E, Zito Marinosci G, Romano GM, Piazza O, Iannuzzi M, Cirillo F, De Simone S, Servillo G

ClinicoEconomics and Outcomes Research 2016, 8:317-322

Published Date: 29 June 2016

Relative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow's milk allergy in Poland

Guest JF, Weidlich D, Kaczmarski M, Jarocka-Cyrta E, Kobelska-Dubiel N, Krauze A, Sakowska-Maliszewska I, Zawadzka-Krajewska A

ClinicoEconomics and Outcomes Research 2016, 8:307-316

Published Date: 28 June 2016

Cost-effectiveness of minimally invasive sacroiliac joint fusion [Corrigendum]

Cher DJ, Frasco MA, Arnold RJG, Polly DW

ClinicoEconomics and Outcomes Research 2016, 8:305-306

Published Date: 27 June 2016

Is the routine use of bevacizumab in the treatment of women with advanced or recurrent cancer of the cervix sustainable?

Klag N, Walter AC, Sheely KM, Manahan KJ, Geisler JP

ClinicoEconomics and Outcomes Research 2016, 8:287-291

Published Date: 21 June 2016

Economic analysis of empiric versus diagnostic-driven strategies for immunocompromised patients with suspected fungal infections in the People's Republic of China

Mao NY, Lesher B, Liu QF, Qin L, Chen YX, Gao X, Earnshaw SR, McDade CL, Charbonneau C

ClinicoEconomics and Outcomes Research 2016, 8:275-285

Published Date: 14 June 2016

A comparison of EuroQol 5-Dimension health-related utilities using Italian, UK, and US preference weights in a patient sample

Mozzi A, Meregaglia M, Lazzaro C, Tornatore V, Belfiglio M, Fattore G

ClinicoEconomics and Outcomes Research 2016, 8:267-274

Published Date: 13 June 2016

Scaling up health knowledge at European level requires sharing integrated data: an approach for collection of database specification

Menditto E, Bolufer de Gea A, Cahir C, Marengoni A, Riegler S, Fico G, Costa E, Monaco A, Pecorelli S, Pani L, Prados-Torres A

ClinicoEconomics and Outcomes Research 2016, 8:253-265

Published Date: 13 June 2016

Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK

Eklund O, Afzal F, Borgström F, Flavin J, Ternouth A, Ojanguren ME, Crespo C, Baldwin M

ClinicoEconomics and Outcomes Research 2016, 8:243-252

Published Date: 11 June 2016

Savings associated with high-dose hypoallergenic house dust mite immunotherapy in rhinitis and/or asthma patients in Spain

García Robaina JC, Polanco Sánchez C, Estella Pérez E

ClinicoEconomics and Outcomes Research 2016, 8:235-241

Published Date: 14 June 2016

Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US

Miller JD, Ye X, Lenhart GM, Farr AM, Tran OV, Kwong WJ, Magnuson EA, Weintraub WS

ClinicoEconomics and Outcomes Research 2016, 8:215-226

Published Date: 20 May 2016

The changing landscape of antiviral treatment of herpes zoster: a 17-year population-based cohort study

Friesen KJ, Alessi-Severini S, Chateau D, Falk J, Bugden S

ClinicoEconomics and Outcomes Research 2016, 8:207-214

Published Date: 20 May 2016

Estimated hospital costs associated with preventable health care-associated infections if health care antiseptic products were unavailable

Schmier JK, Hulme-Lowe CK, Semenova S, Klenk JA, DeLeo PC, Sedlak R, Carlson PA

ClinicoEconomics and Outcomes Research 2016, 8:197-205

Published Date: 13 May 2016

Economic burden of refractory chronic spontaneous urticaria on Kuwait's health system

Al-Ahmad M, Alowayesh MS, Carroll NV

ClinicoEconomics and Outcomes Research 2016, 8:163-169

Published Date: 10 May 2016

Cost-effectiveness of bortezomib for multiple myeloma: a systematic review

Chen W, Yang Y, Chen Y, Du F, Zhan H

ClinicoEconomics and Outcomes Research 2016, 8:137-151

Published Date: 3 May 2016

Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand

Boonlue T, Subongkot S, Dilokthornsakul P, Kongsakon R, Pattanaprateep O, Suanchang O, Chaiyakunapruk N

ClinicoEconomics and Outcomes Research 2016, 8:127-136

Published Date: 29 April 2016

A burden of illness study for neuropathic pain in Europe

Liedgens H, Obradovic M, De Courcy J, Holbrook T, Jakubanis R

ClinicoEconomics and Outcomes Research 2016, 8:113-126

Published Date: 27 April 2016

Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke

Johnson BH, Bonafede MM, Watson C

ClinicoEconomics and Outcomes Research 2016, 8:53-61

Published Date: 23 February 2016

Costs associated with rheumatoid arthritis in Italy: past, present, and future

Benucci M, Rogai V, Atzeni F, Hammen V, Sarzi-Puttini P, Migliore A

ClinicoEconomics and Outcomes Research 2016, 8:33-41

Published Date: 10 February 2016

Ignoring the sacroiliac joint in chronic low back pain is costly

Polly DW, Cher D

ClinicoEconomics and Outcomes Research 2016, 8:23-31

Published Date: 21 January 2016

Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: a multicenter regional simulation

Cenderello G, Artioli S, Viscoli C, Pasa A, Giacomini M, Giannini B, Dentone C, Nicolini LA, Cassola G, Di Biagio A

ClinicoEconomics and Outcomes Research 2016, 8:15-21

Published Date: 31 December 2015

Cost-effectiveness of minimally invasive sacroiliac joint fusion

Cher DJ, Frasco MA, Arnold RJG, Polly DW

ClinicoEconomics and Outcomes Research 2016, 8:1-14

Published Date: 18 December 2015